Citations

Citations to this article as recorded by  

• Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis
  Jialin Su, Yuning Li, Shuhua Tan, Tianli Cheng, Yongzhong Luo, Lemeng Zhang
  Scientific Reports.2025;[Epub]     CrossRef
• Prognostic value of liver metastasis in patients with esophageal squamous cell carcinoma treated with nivolumab
  Ryuichi Morita, Takeshi Ishikawa, Toshifumi Doi, Junichiro Itani, Daiki Sone, Naoto Iwai, Ken Inoue, Hirotaka Konishi, Osamu Dohi, Naohisa Yoshida, Atsushi Shiozaki, Kazuhiko Uchiyama, Tomohisa Takagi, Hitoshi Fujiwara, Hideyuki Konishi, Yoshito Itoh
  Oncology Letters.2025;[Epub]     CrossRef
• Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma
  Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu
  World Journal of Surgical Oncology.2025;[Epub]     CrossRef
• The prognostic value of pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with esophageal cancer undergoing immunotherapy: a systematic review and meta-analysis
  Min Deng, Yun Qing, Dan Qiu, Ya Sheng, Juan Zhou, Lan Sun
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Effectiveness, safety, and patterns of use of camrelizumab in advanced esophageal cancer: an individual patient data pooled analysis of 987 patients from three prospective cohort studies
  Zhihao Lu, Guoping Sun, Jiancheng Li, Jun Zhao, Zishu Wang, Dong Qian, Zhe Yang, Na Li, Junsheng Wang, Shuanghu Yuan, Yusheng Wang, Suyi Li, Zhen Yang, Fengming Ran, Yinghua Ji, Shaojin Zhu, Yanqiao Zhang, Chen Wang, Lixin Wan, Rongrong Zheng, Wenjie Deng
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• Nutritional management during chemotherapy and chemoradiotherapy for advanced esophageal cancer
  Yutaka Kimura, Atsushi Gakuhara, Shuichi Fukuda, Yasunari Fukuda, Terukazu Yoshihara, Chikato Koga, Naotsugu Haraguchi, Jin-ichi Hida
  Esophagus.2025;[Epub]     CrossRef
• Prognostic value of the pretreatment Glasgow prognostic score or modified Glasgow prognostic score in patients with advanced cancer receiving immune checkpoint inhibitors: A systematic review and meta‑analysis
  Lianghui Zhang, Lili Lin, Jie Ni, Tao Ling, Lingli Huang
  Oncology Letters.2025; 30(1): 1.     CrossRef
• Clinical features and treatment outcomes of PD-1 inhibitor therapy in elderly patients (≥ 65 years) with advanced esophageal squamous cell carcinoma: a real-world study
  Yi Yu, Tao Wu, Wei Gan, Can Liu, Ran Zhang, Jinxiu Zheng, Jianping Xiong, Jun Chen, Junhe Li
  Clinical and Translational Oncology.2024; 26(9): 2360.     CrossRef
• Pembrolizumab for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus: a drug safety evaluation
  Kazumasa Yamamoto, Shun Yamamoto, Ken Kato
  Expert Opinion on Drug Safety.2024; 23(6): 667.     CrossRef
• Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort
  Tomoki Makino, Shigeto Nakai, Kota Momose, Kotaro Yamashita, Koji Tanaka, Hiroshi Miyata, Sachiko Yamamoto, Masaaki Motoori, Yutaka Kimura, Yuki Ushimaru, Motohiro Hirao, Jin Matsuyama, Yusuke Akamaru, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki
  Esophagus.2024; 21(3): 319.     CrossRef
• The impact of antibiotic use in gastrointestinal tumors treated with immune checkpoint inhibitors: systematic review and meta-analysis
  Faizah M. Alotaibi, Ibrahim Abdullah S. Albalawi, Amna M. Anis, Hawazin Alotaibi, Seham Khashwayn, Kanan Alshammari, Jaffar A. Al-Tawfiq
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases
  Sho Sato, Takashi Suzuki, Takashi Chinen, Hironori Yamaguchi, Yusuke Suzuki, Nobukazu Hokamura, Zenichiro Saze, Koji Kono, Keita Takahashi, Fumiaki Yano, Tsutomu Sato, Takashi Kosaka, Itaru Endo, Yasushi Ichikawa, Yutaka Miyawaki, Hiroshi Sato, Hideaki Sh
  Journal of Gastroenterology.2024; 59(11): 979.     CrossRef
• Prognostic biomarkers for immunotherapy in esophageal cancer
  Xu Tong, Meiyuan Jin, Lulu Wang, Dongli Zhang, Yuping Yin, Qian Shen
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
  Lilong Zhang, Wangbin Ma, Zhendong Qiu, Tianrui Kuang, Kunpeng Wang, Baohong Hu, Weixing Wang
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors
  Hyejee Ohm, Omar Abdel-Rahman
  Current Oncology.2023; 30(1): 786.     CrossRef
• A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors
  Athéna Crespin, Clément Le Bescop, Jean de Gunzburg, Fabien Vitry, Gérard Zalcman, Julie Cervesi, Pierre-Alain Bandinelli
  Frontiers in Oncology.2023;[Epub]     CrossRef
• The Use of Antibiotics During Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Advanced Esophagogastric Cancer
  Lilong Zhang, Tianrui Kuang, Dongqi Chai, Wenhong Deng, Peng Wang, Weixing Wang
  International Immunopharmacology.2023; 119: 110200.     CrossRef
• Predictive Impact of Prognostic Nutritional Index in Patients with Cancer Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
  Xin-Tian Xu, Yu Qian, Meng-Xing Tian, Chen-Chen Ding, Huan Guo, Jing Tang, Guo-Liang Pi, Yuan Wu, Zhu Dai, Xin Jin
  Nutrition and Cancer.2023; 75(6): 1413.     CrossRef
• Immune checkpoint inhibitors in the treatment of oesophageal squamous cell carcinoma: where are we and where are we going?
  Ning Chen, Xiaoling Xu, Yun Fan
  Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
• 進行食道癌に対する化学療法，化学放射線療法における栄養管理
  豊 木村
  The Japanese Journal of SURGICAL METABOLISM and NUTRITION.2023; 57(6): 183.     CrossRef
• Prognostic and predictive impact of neutrophil‐to‐lymphocyte ratio and HLA‐I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy
  Lin Wang, Yanrong Zhu, Bo Zhang, Xi Wang, Hongnan Mo, Yuchen Jiao, Jiachen Xu, Jing Huang
  Thoracic Cancer.2022; 13(11): 1631.     CrossRef
• Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
  Liwei Ni, Jing Huang, Jiyuan Ding, Junyan Kou, Tingting Shao, Jun Li, Liujie Gao, Wanzhen Zheng, Zhen Wu
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
  Jiaxin Zhou, Guowei Huang, Wan-Ching Wong, Da-hai Hu, Jie-wen Zhu, Ruiman Li, Hong Zhou
  Frontiers in Immunology.2022;[Epub]     CrossRef
• The prognostic value of prognostic nutritional index in advanced cancer receiving PD‐1/L1 inhibitors: A meta‐analysis
  Pengfei Li, Yutian Lai, Long Tian, Qinghua Zhou
  Cancer Medicine.2022; 11(16): 3048.     CrossRef
• Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade
  Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Chan Kim
  Journal for ImmunoTherapy of Cancer.2022; 10(6): e004799.     CrossRef
• Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review
  Yusheng Guo, Dongqiao Xiang, Jiayu Wan, Lian Yang, Chuansheng Zheng
  Cancers.2022; 14(21): 5297.     CrossRef
• The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
  Deniz Can Guven, Taha Koray Sahin, Enes Erul, Alessandro Rizzo, Angela Dalia Ricci, Sercan Aksoy, Suayib Yalcin
  Frontiers in Molecular Biosciences.2022;[Epub]     CrossRef
• Nomogram Based on Monocyte-to-Lymphocyte Ratio to Predict Survival of Unresectable Esophageal Squamous Cell Carcinoma Who Receive First-Line PD-1/PD-L1 Inhibitors Combined with Chemotherapy
  Xiaolu Ma, Yongfeng Ding, Jiong Qian, Mingyu Wan, Ning Li, Chenyu Mao, Cheng Xiao, Haiping Jiang, Yulong Zheng, Luntao Wu, Xiaoyu Chen, Nong Xu
  Current Oncology.2022; 29(11): 8937.     CrossRef

Citations

Citations to this article as recorded by  

• Unveiling Lipid Metabolic Shifts in Different Stages of Oral Submucous Fibrosis: A New Horizon in Predicting Malignant Transformation
  Akhilesh Chandra, R Keerthika, Rahul Agarwal, Arpita Rai, Mahesh Khairnar
  Indian Journal of Otolaryngology and Head & Neck Surgery.2025; 77(2): 659.     CrossRef
• Impact of dyslipidemia and lipid‐lowering therapy with statins in patients with neuroendocrine tumors
  Antongiulio Faggiano, Flaminia Russo, Virginia Zamponi, Franz Sesti, Giulia Puliani, Roberta Modica, Pasqualino Malandrino, Francesco Ferraù, Maria Rinzivillo, Marco Di Muzio, Emanuele Di Simone, Nicolò Panattoni, Pasquale Dolce, Rosa Lauretta, Gianfranco
  Journal of Neuroendocrinology.2025;[Epub]     CrossRef
• Correlation between Metabolic Syndrome and Gastric Cancer: Results of an Evidence-Based Strategy in Oriental Populations
  Tong Liang, Junhong Wang, Zhenhua Gao, Mingxu Da
  Combinatorial Chemistry & High Throughput Screening.2025; 28(2): 254.     CrossRef
• Assessing gastric cancer risk through longitudinal health check-up data: Insights from a national cohort study in South Korea
  Juwon Park, Do-young Kim, Mina Suh, Yeong-Hwa Kim, Sungho Won, Patricia Khashayar
  PLOS ONE.2025; 20(4): e0312861.     CrossRef
• Whole-Exome Sequencing Identified Molecular Variants Linked to the Progression of Gastric Precancerous Lesions in Patients from Southwestern Colombia—An Exploratory Approach
  Lizeth Mejia-Ortiz, Jovanny Zabaleta, Jone Garai, Luis Eduardo Bravo, Andres Castillo
  Gastrointestinal Disorders.2025; 7(2): 30.     CrossRef
• 27-Hydroxycholesterol in cancer development and drug resistance
  Yaxin Hou, Zhiguang Fu, Chenhui Wang, Paulina Kucharzewska, Yuan Guo, Sihe Zhang
  Journal of Enzyme Inhibition and Medicinal Chemistry.2025;[Epub]     CrossRef
• Mendelian Randomization Assessment of the Genetic Effects of Lipid‐Lowering Drugs on Digestive System Cancers
  Keru Ma, Hao Wang, Yubo Du, Tianyu Chen, Dongxu Yang, Yue Li, Dalin Li
  Food Science & Nutrition.2025;[Epub]     CrossRef
• Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases
  Sutanu Sarkar, Deotima Roy, Bhaskar Chatterjee, Rajgourab Ghosh
  Metabolomics.2024;[Epub]     CrossRef
• Causal relationships between coffee intake, apolipoprotein B and gastric, colorectal, and esophageal cancers: univariable and multivariable Mendelian randomization
  Xingwu Liu, Han Yu, Guanyu Yan, Boyang Xu, Mingjun Sun, Mingliang Feng
  European Journal of Nutrition.2024; 63(2): 469.     CrossRef
• Development of a gastric cancer risk calculator for questionnaire-based surveillance of Iranian dyspeptic patients
  Kimiya Gohari, Samaneh Saberi, Maryam Esmaieli, Mohammad Tashakoripour, Mahmoud Eshagh Hosseini, Azin Nahvijou, Mohammad Ali Mohagheghi, Anoshirvan Kazemnejad, Marjan Mohammadi
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Lipid droplets provide metabolic flexibility for cancer progression
  Rémi Safi, Pablo Menéndez, Albert Pol
  FEBS Letters.2024; 598(10): 1301.     CrossRef
• Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study
  Kwangwoo Nam, Su Youn Nam, Jun Chul Park, Young Sin Cho, Hyuk Soon Choi, Kyoungwon Jung, Seon-Young Park, Joon Hyun Cho, Hyonho Chun
  Digestive and Liver Disease.2024; 56(9): 1592.     CrossRef
• The role of triglyceride/high-density lipoprotein cholesterol ratio in the prediction of intensive care unit admission in the earthquake victims
  Süleyman Akkaya, Ümit Çakmak
  Dicle Tıp Dergisi.2024; 51(1): 80.     CrossRef
• Associations of dietary factors with gastric cancer risk: insights from NHANES 2003–2016 and mendelian randomization analyses
  Yigang Zhang, Sen Wang, Qingya Li, Hongda Liu, Zhe Xuan, Fengyuan Li, Zheng Li, Yiwen Xia, Tianlu Jiang, Penghui Xu, Lang Fang, Linjun Wang, Diancai Zhang, Hao Xu, Li Yang, Zekuan Xu
  Frontiers in Genetics.2024;[Epub]     CrossRef
• Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study
  Wenjing Ding, Liangliang Chen, Jianguo Xia, Bei Pei, Biao Song, Xuejun Li
  Medicine.2024; 103(18): e38010.     CrossRef
• Statins as anti‐tumor agents: A paradigm for repurposed drugs
  Sneha Tripathi, Ekta Gupta, Sanjeev Galande
  Cancer Reports.2024;[Epub]     CrossRef
• Correlation study of serum lipid levels and lipid metabolism-related genes in cervical cancer
  Lin Cheng, Zhuo Li, Qingmei Zheng, Qin Yao
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Association between serum total cholesterol and the development of gastric cancer: A two-way two-sample Mendelian randomization study
  Peng Yan, Dong Zhao
  Medicine.2024; 103(28): e38900.     CrossRef
• Serum Lipid Levels, Genetic Risk, and Lung Cancer Incidence: A Large Prospective Cohort Study
  Jing Wang, Qi Wang, Ziwei Shi, Xiaolong Yan, Zhiqun Lei, Wenmin Zhu
  Cancer Epidemiology, Biomarkers & Prevention.2024; 33(7): 896.     CrossRef
• Blood lipid profiles associated with metastatic sites in advanced gastric cancer
  Hui Zhang, Yiming Liu, Li Feng, Long Wang, Jing Han, Xue Zhang, Yudong Wang, Dan Li, Jiayin Liu, Yan Liu, Hui Jin, Zhisong Fan
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Lipid levels and insulin resistance markers in gastric cancer patients: diagnostic and prognostic significance
  Di Zhang, Ren-hao Hu, Xi-mao Cui, Xiao-hua Jiang, Shun Zhang
  BMC Gastroenterology.2024;[Epub]     CrossRef
• Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients
  Qiliang Peng, Changli Zhan, Yi Shen, Yao Xu, Bixin Ren, Zhengyang Feng, Yong Wang, Yaqun Zhu, Yuntian Shen
  BMC Cancer.2024;[Epub]     CrossRef
• Lipid Profiles, Telomere Length, and the Risk of Malignant Tumors: A Mendelian Randomization and Mediation Analysis
  Shupeng Liu, Zhengzheng Fu, Hui Liu, Yinghui Wang, Meijuan Zhou, Zhenhua Ding, Zhijun Feng
  Biomedicines.2024; 13(1): 13.     CrossRef
• Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer
  Chengjun Zhu, Mengpei Yan, Zhijun Zhang, Yikai Shen, Wangwen Wang, Zetian Chen, Changsheng Cai, Hongda Liu, Zekuan Xu, Zheng Li
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Impact of serum lipid on recurrence of uterine fibroids: a single center retrospective study
  Yimin Ma, Jingjing Weng, Yingying Zhu
  BMC Women's Health.2024;[Epub]     CrossRef
• Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemia
  Shenrui Bai, Huizhong Wang, Ruonan Shao, Bibo Fu, Shujing Lu, Jingzi Wang, Yue Lu, Hua Wang
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Association of plasma lipid metabolism profiles with overall survival for patients with gastric cancer undergoing gastrectomy based on 1H-NMR spectroscopy
  Yaopeng Qiu, Zhou Xu, Qingfeng Xie, Renyi Zhang, Luyao Wang, Liying Zhao, Hao Liu
  Nutrition & Metabolism.2023;[Epub]     CrossRef
• Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
  Yuan Li, Chunliang Shang, Huamao Liang, Kun Zhang, Yu Wu, Hongyan Guo
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy
  Fan Cui, Huiyu Zhou, Dingyang Lv, Jie Wen, Qian Gong, Yi Rong, Yinbo Kang, Mohan Jia, Weibing Shuang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• The association between serum lipid profile and the prostate cancer risk and aggressiveness
  Jungyo Suh, Teak Jun Shin, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Dyslipidemia in diffuse large B-cell lymphoma based on the genetic subtypes: a single-center study of 259 Chinese patients
  Yi Xu, Huafei Shen, Yuanfei Shi, Yanchun Zhao, Xiaolong Zhen, Jianai Sun, Xueying Li, De Zhou, Chunmei Yang, Jinhan Wang, Xianbo Huang, Juying Wei, Jian Huang, Haitao Meng, Wenjuan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Association of triglyceride/high-density lipoprotein cholesterol ratio with severe complications of COVID-19
  Yoonkyung Chang, Jimin Jeon, Tae-Jin Song, Jinkwon Kim
  Heliyon.2023; 9(6): e17428.     CrossRef
• Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis
  Shicong Xu, Ying Fan, Yuyue Tan, Ling Zhang, Xianrong Li, Ozra Tabatabaei-Malazy
  PLOS ONE.2023; 18(7): e0288111.     CrossRef
• Recent research progress on the correlation between metabolic syndrome and Helicobacter pylori infection
  Qinli Xie, Yangjun He, Danni Zhou, Yi Jiang, Ying Deng, Ruoqing Li
  PeerJ.2023; 11: e15755.     CrossRef
• Increased age, bilirubin, international normalized ratio, and creatinine score to triglyceride ratio are associated with alcohol-associated primary liver carcinoma: a single-centered retrospective study
  Xiaoqing Jia, Rong Li, Xiaoting Zhang, Tao Zhou, Dalong Sun, Na Yang, Zheng Luo
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• The Impact of Modern Dietary Practices on Cancer Risk and Progression: A Systematic Review
  Stephanie Nagy, Stephanie N Petrosky, Michelle Demory Beckler, Marc M Kesselman
  Cureus.2023;[Epub]     CrossRef
• Risk of gastric cancer in relation with serum cholesterol profiles: A nationwide population-based cohort study
  Mi Jin Oh, Kyungdo Han, Bongseong Kim, Joo Hyun Lim, Bokyung Kim, Sang Gyun Kim, Soo-Jeong Cho
  Medicine.2023; 102(48): e36260.     CrossRef
• ApoA-I and ApoB levels, and ApoB-to-ApoA-I ratio as candidate pre-treatment biomarkers of pathomorphological response to neoadjuvant therapy in gastric and esophago-gastric junction adenocarcinoma
  Kamil Nurczyk, Norbert Nowak, Tomasz Orczykowski, Paweł Bojar, Dariusz Duma , Renata Gieroba, Grzegorz Wallner, Tomasz Skoczylas
  Polish Journal of Surgery.2023; 96(2): 44.     CrossRef
• Risk Factors to Predict Ocular Metastasis in Older Adult Patients With Gastric Cancer:LDL, ApoA1, and CA724
  Wen-Qing Shi, Shi-Nan Wu, Tie Sun, Hui-Ye Shu, Qi-Chen Yang, Qiu-Yu Li, Ting Su, Yi-Cong Pan, Rong-Bin Liang, Yi Shao
  Technology in Cancer Research & Treatment.2022;[Epub]     CrossRef
• Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
  Chang-Feng Deng, Neng Zhu, Tan-Jun Zhao, Hong-Fang Li, Jia Gu, Duan-Fang Liao, Li Qin
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway
  Danping Sun, Mingxiang Zhang, Meng Wei, Zhaoyang Wang, Wen Qiao, Peng Liu, Xin Zhong, Yize Liang, Yuanyuan Chen, Yadi Huang, Wenbin Yu
  Aging.2022; 14(9): 3887.     CrossRef
• Postoperative high-density lipoprotein cholesterol level: an independent prognostic factor for gastric cancer
  Chenxi Li, Yan Fu, Qiuwen Li, Xuhui Yang, Wenying Wang, Xin Jin, Lihua Bian, Hui Zhao, Donghui Li, Jie Gao, Nan Du, Liang Peng
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
  Junhong Li, Cong Ma, Xuhui Yuan, Xiaoyan Wang, Na Li, Ronghui Yu, Hui Liao
  Current Oncology.2022; 29(9): 6125.     CrossRef
• Significance of Decreased Serum High-density Lipoprotein Cholesterol Levels in Patients with Gastric Cancer
  Tae Ho Kim
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 175.     CrossRef
• Clinical Value on Combined Detection of Serum CA724, DKK1, and TK1 in Diagnosis of Gastric Cancer
  Yu Wang, Dongqing Cui, Di Li, Dan Li, Honglei Wang, Yu Wu, Alamgeer Yuchi
  Journal of Oncology.2022; 2022: 1.     CrossRef
• Adverse effects of low serum lipoprotein cholesterol on the immune microenvironment in gastric cancer: a case‒control study
  Yi Zou, Xiaoyan Yu, Chenqi Zhou, Chunpeng Zhu, Ying Yuan
  Lipids in Health and Disease.2022;[Epub]     CrossRef
• Influence of cholesterol on cancer progression and therapy
  Shyamananda Singh Mayengbam, Abhijeet Singh, Ajay D. Pillai, Manoj Kumar Bhat
  Translational Oncology.2021; 14(6): 101043.     CrossRef
• Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study
  Fan Luo, Kang-mei Zeng, Jia-xin Cao, Ting Zhou, Su-xia Lin, Wen-juan Ma, Yun-peng Yang, Zhong-han Zhang, Fei-teng Lu, Yan Huang, Hong-yun Zhao, Li Zhang
  Lipids in Health and Disease.2021;[Epub]     CrossRef